Total raised
—
Stage
Pre-Funding
Founded
2021
Headcount
1
HQ
Petah Tikva
Sector
Health Tech & Life Sciences
About
BioPass Pharma is developing a revolutionary formulation intended for the treatment of brain or CNS diseases utilizing its patented novel technology, which is designed to deliver molecules directly into the brain by bypassing the BBB.
Its novel nasal formulation offers short onset of a non-invasive, painless, easily administered treatment, avoiding gastrointestinal and hepatic presystemic metabolism.
BioPass Pharma has secured exclusive rights for this technology from the Hebrew University of Jerusalem.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcarePatients
Business model
B2B
Highlights
1 PatentsVerified
Tags
cns-disordersdrug-discoverytargeted-therapydrug-deliverynon-invasivepharmaceuticalsnanotechnology